Urothelial carcinoma of the bladder: definition, treatment and future efforts. - Wikidata - wikimedia - TriplyDB

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

http://www.wikidata.org/entity/Q37944437

about

Normal and neoplastic urothelial stem cells: getting to the root of the problem Protein Profiling of Bladder Urothelial Cell Carcinoma Genetic and Epigenetic Alterations in Bladder Cancer MicroRNAs as biomarkers associated with bladder cancer.Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).Knockdown of regulator of cullins-1 (ROC1) expression induces bladder cancer cell cycle arrest at the G2 phase and senescence.Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.Modelling bladder cancer in mice: opportunities and challenges.MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6 Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor.The prognostic significance of DAPK1 in bladder cancer.CMTM8 inhibits the carcinogenesis and progression of bladder cancer Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.Alterations of DNA methylome in human bladder cancer.Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells.Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.Urothelial generation and regeneration in development, injury, and cancer.Do histological variants in urothelial carcinoma of the bladder portend poor prognosis? A systematic review and meta-analysis Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells.Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.Bladder cancers arise from distinct urothelial sub-populations.Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors.Inflammatory microenvironment in the initiation and progression of bladder cancer.Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.The Stromal Niche for Epithelial Stem Cells: A Template for Regeneration and a Brake on Malignancy.Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression.Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

P2860

Q26825948-E761E59E-C741-4E19-AEFF-C8EE0DDAA844 Q27324419-C8AB0B88-06F3-435C-A9A8-258CAC673C78 Q28074732-8E077551-383A-4A2C-A45C-EF1E227A53CB Q33642335-9BC63B69-5532-4661-AD8D-2BAA752F54F6 Q33919252-F2452680-6ECC-4148-AF3C-9F885EDBE44C Q34717627-388D79A6-CC92-496C-BE41-9A538D3D463E Q35022673-41E987E0-9E32-4590-8697-A2E8C6E96CB3 Q35056092-65DCF5EB-898F-48D0-B67A-34D478C9EDC3 Q35285703-D5DAE277-E0B3-4EBC-8B22-6520B73C1E6A Q35605883-BA4CB668-32F8-4648-99B7-83681A6BC2B8 Q35956711-B19E0FF2-DB45-48D2-9658-77082C1F1372 Q36272100-70E3993A-51E2-408F-92AF-EC8C70A6C0ED Q36339910-CFC7893A-C477-47E0-AD89-49061B83D528 Q36490303-69231F6C-D01B-40CB-840B-4E02DFAD3BD9 Q36557362-3DCA753E-0D08-4A4F-B577-92FA028B827D Q36574137-FC9278D5-3645-4BA4-BA7E-FAF58747E4C5 Q36739002-727A3794-9B65-4C2C-8475-2CEE8252749F Q37256055-AF286732-96B5-43ED-BBD5-22DDD825F750 Q37317523-514D3C7A-D103-40A6-A732-DB127B3F8092 Q38131409-6EE90745-2471-4477-86CE-06E0397F0A5D Q38686052-B81D049F-8B2F-4C3A-8804-833DB49BDC32 Q38715315-9465222D-689F-4AB0-B225-BCE2696749B7 Q38721568-B2C3AA1F-9065-4754-9AB2-0AB86000694B Q39038597-DCC8589E-340F-4BC1-B2A0-0D01C14F4229 Q39097235-544CE797-38A4-41F3-96A8-18E4977D51F1 Q39318239-B7EB5BF9-0808-48C2-AD2E-244BD4FF69E6 Q39404314-CA632B8E-5FCF-44B8-9A72-18CC4B852AEA Q41339763-B86B1803-4EDA-4FEF-868F-84801D118C63 Q41486372-E738601E-21EA-4C80-965D-7D10F70996CD Q42378347-3839BCEF-8443-465C-B35F-7CA8755B97B5 Q42465565-BBB7E302-F985-456A-8017-FE6FB8CEEF6C Q43717784-50B11AAF-1842-45F9-B35C-B6A80B5AFB66 Q44581657-B7A74098-08DB-44B2-8AC4-E095047B862F Q46779353-2D23A7B1-B1E9-4DCF-AA65-2E4CA6D97F01 Q47170529-7C03A535-1E4A-48D4-8C87-38E2DA316650 Q47670544-E3DFAD9E-B5DB-43E3-A6B2-D6538582FB77 Q47694209-BC5A2CB9-1A55-42F4-B6BA-86B66E70824A Q47727562-92CD50BB-4AE9-401D-AF22-D7D92FB3C831 Q48225163-5E1C784B-47B4-4475-B167-A73903683BC7 Q49168184-1002040A-7067-4A94-B06B-E3A6FF92AC42

P2860

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

http://www.wikidata.org/entity/Q37944437

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@en

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@nl

type

label

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@en

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@nl

prefLabel

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@en

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@nl

P1433

Q37944437-8ED8599B-4D06-43EA-BD41-992D1F9EFED9

P1476

Q37944437-C6390E63-A320-4805-A957-EEB538711503

P2093

Q37944437-4006A214-DB2E-43C2-870F-9B5AF5F0B9F5

Q37944437-6C156414-1FC3-44FB-86A2-80E6BDD5A12F

Q37944437-80BCA44D-CCD6-480B-B3FF-1A48A15FB91B

Q37944437-BC38E8D8-4DD9-4DB7-9923-707BA9CEFB4B

P2860

Q37944437-016ACEF8-0EAE-4E9E-92EB-6C4A48FC737E

Q37944437-01929719-1900-4202-9AEC-DE727AFDE4F8

Q37944437-0364CFBB-F3A4-40B7-88EA-9ED1E24B44A7

Q37944437-03E29BD8-87CC-4642-91BD-2714C96EA6D6

Q37944437-0B5594D3-1E91-4D30-A859-833107C86443

Q37944437-0E1383DA-B50F-4454-B03D-3934DDE80688

Q37944437-0FE5183E-335B-49AD-8A45-4E668772B4A1

Q37944437-12A8C25C-7BBB-4020-8C13-D4949827C852

Q37944437-1B089387-9B59-4C7A-A9D5-250FF7EEB186

Q37944437-1C63ED29-EB25-4C2D-A348-5695BAA453EF

P2888

Q37944437-A822DF29-DAE5-42AC-858E-DA80AC077E33

P304

Q37944437-F7A171A5-709E-4518-82B0-1049E32731A6

P31

Q37944437-2D627876-D62B-4EAF-A1BF-F936491245B6

P356

Q37944437-28F52F69-0B27-45C8-8F20-7FD1D12E31DA

P407

Q37944437-D8CB7AC4-68D8-49B3-851D-B981CA36CA51

P433

Q37944437-59D05214-02D7-4896-86CB-18ED580D7FA1

P478

Q37944437-20B4A6F8-F622-48C1-8F9A-21726F080F77

P577

Q37944437-2EBCEB33-19AB-4742-BAF5-E4CEA9896701

P698

Q37944437-0A625414-A9F5-4DD3-86B5-7A68B88B2461

P356

NRUROL.2011.144

P1433

Nature Reviews Urology

P1476

Urothelial carcinoma of the bladder: definition, treatment and future efforts.

@en

P2093

G Joel Decastro

http://www.w3.org/2001/XMLSchema#string

Gary D Steinberg

http://www.w3.org/2001/XMLSchema#string

Medscape

http://www.w3.org/2001/XMLSchema#string

Sandip M Prasad

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

The cancer genome

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

P2888

nrurol.2011.144

P304

631-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2011.144

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21989305

http://www.w3.org/2001/XMLSchema#string